Literature DB >> 20505329

Intracellular accumulation of cell cycle regulatory proteins and nucleolin re-localization are associated with pre-lethal ultrastructural lesions in circulating T lymphocytes: the HIV-induced cell cycle dysregulation revisited.

Giuseppa Visalli1, Mirko Paiardini, Cristina Chirico, Barbara Cervasi, Monica Currò, Nadia Ferlazzo, Maria Paola Bertuccio, Angelo Favaloro, Giovanni Pellicanò, Giuseppe Sturniolo, Pasquale Spataro, Riccardo Ientile, Isa Picerno, Giuseppe Piedimonte.   

Abstract

The HIV-induced demise of CD4-T cells is thought to be a result of the execution of genetically programmed cell death that occurs in lymphoid tissue, where many resident T cells are chronically hyperactivated. Since HIV-induced alterations of cell cycle control has been often indicated as prominent mechanism of immune hyper activation and cause of apoptotic death, the signal pathway involved in cell cycle dysregulation of T lymphocytes from HIV infected patients was extensively studied. Here, we also demonstrate that circulating T lymphocytes leave lymphoid tissues with diffused regressive lesions (vacuolization, blebbing, nuclear evanescence and organelle swelling). Equally diffused are biochemical anomalies that accompany the overall disarrangement of cell structure, particularly the fragmentation and diffusion into the cytoplasm of C23/nucleolin, the intracellular accumulation of short lived regulatory proteins and the decrease in expression of membrane proteins. All this is something more than a cell cycle-related remodelling of cell morphology and biochemical mechanisms, and rather recalls a necrotic/oncotic cell damage. Since these changes are associated with adaptive mechanisms to hypoxia, we give evidence for alteration of cell cycle control developing in conditions of scarce energy supply.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505329     DOI: 10.4161/cc.9.11.11754

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  6 in total

1.  [Effect of nucleolin silencing on differentiation of rat neural stem cells in vitro and the molecular mechanism].

Authors:  Chong-Feng Chen; Huai-Cai Yang; Guo-Sheng Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-07-20

2.  The cytosolic protein G0S2 maintains quiescence in hematopoietic stem cells.

Authors:  Takeshi Yamada; Chun Shik Park; Audrea Burns; Daisuke Nakada; H Daniel Lacorazza
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

3.  Nucleolin stabilizes G-quadruplex structures folded by the LTR promoter and silences HIV-1 viral transcription.

Authors:  Elena Tosoni; Ilaria Frasson; Matteo Scalabrin; Rosalba Perrone; Elena Butovskaya; Matteo Nadai; Giorgio Palù; Dan Fabris; Sara N Richter
Journal:  Nucleic Acids Res       Date:  2015-09-09       Impact factor: 16.971

4.  Unusual Signs and Symptoms in HIV-Positive Patients Coinfected with Leishmania spp: The Importance of Neglected Tropical Disease in Differential Diagnosis.

Authors:  Manuela Ceccarelli; Emmanuele Venanzi Rullo; Fabrizio Condorelli; Fabrizio Vitale; Vincenzo Di Marco; Giuseppe Nunnari; Giovanni Francesco Pellicanò
Journal:  Open Access Maced J Med Sci       Date:  2018-04-25

Review 5.  Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review.

Authors:  Manuela Ceccarelli; Emmanuele Venanzi Rullo; Alessio Facciolà; Giordano Madeddu; Bruno Cacopardo; Rosaria Taibi; Francesco D'Aleo; Marilia Rita Pinzone; Isa Picerno; Michele di Rosa; Giuseppa Visalli; Fabrizio Condorelli; Giuseppe Nunnari; Giovanni Francesco Pellicanò
Journal:  Oncotarget       Date:  2018-03-30

6.  Vitamin D Status Modulates Inflammatory Response in HIV+ Subjects: Evidence for Involvement of Autophagy and TG2 Expression in PBMC.

Authors:  Monica Currò; Giuseppa Visalli; Giovanni Francesco Pellicanò; Nadia Ferlazzo; Maria Giovanna Costanzo; Flavia D'Andrea; Daniela Caccamo; Giuseppe Nunnari; Riccardo Ientile
Journal:  Int J Mol Sci       Date:  2020-10-13       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.